Talk Bio

FDA Places Partial Hold on Biohaven’s Epilepsy Drug After $350 Million Licensing Deal

Patient Death Triggers FDA Partial Clinical Hold on MacroGenics' LINNET Trial for Gynecologic Cancers

FDA places partial clinical hold on Merck and Daiichi Sankyo’s I-DXd lung cancer trial after interstitial lung disease deaths